Protection against Covid-19 by BNT162b2 Booster across Age Groups

Posted on | Posted on John Murphy | Leave a Comment on Protection against Covid-19 by BNT162b2 Booster across Age Groups

Authors. Yinon M. Bar-On, M.Sc., Yair Goldberg, Ph.D., Micha Mandel, Ph.D., Omri Bodenheimer, M.Sc., Laurence Freedman, Ph.D., Sharon Alroy-Preis, M.D., Nachman Ash, M.D., Amit Huppert, Ph.D., and Ron Milo, Ph.D. Abstract BACKGROUND After promising initial results from the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) to persons 60 years of age or older, the booster campaign in […]

Long COVID in Children

Posted on | Posted on John Murphy | Leave a Comment on Long COVID in Children

Observations From a Designated Pediatric Clinic Authors: Ashkenazi-Hoffnung, Liat MD*,†; Shmueli, Einat MD*,†; Ehrlich, Shay MD*,†; Ziv, Adi MD*,†; Bar-On, Ophir MD*,†; Birk, Einat MD*,†; Lowenthal, Alexander MD*,†; Prais, Dario MD*,† Abstract Systematic data are lacking on pediatric long COVID. This study prospectively assessed 90 children with persistent symptoms who presented to a designated multidisciplinary […]

Spotting Long COVID Symptoms in Children

Posted on | Posted on John Murphy | Leave a Comment on Spotting Long COVID Symptoms in Children

Authors: Katie Sweeney Published on November 17, 2021 Categories: COVID-19, Hospital Programs It’s one of the more mysterious aspects of COVID-19—a condition called long COVID. While most people recover from the virus within two to four weeks, others can struggle for months afterward with lingering, often debilitating symptoms. Long COVID has been most commonly talked about in adults, but children […]

What Happens When Kids Get Long COVID?

Posted on | Posted on John Murphy | Leave a Comment on What Happens When Kids Get Long COVID?

Authors: KATHY KATELLA  NOVEMBER 2, 2021 Yale’s pediatric post-COVID program provides care, while doctors aim to learn more. Doctors are working to understand why some children and adolescents who get COVID-19 make a clean recovery, while others go on to develop long COVID, a condition marked by new, returning, or ongoing symptoms such as brain fog and chronic […]

Children with long covid

Posted on | Posted on John Murphy | Leave a Comment on Children with long covid

Authors: Helen Thomson New Sci. 2021 Feb 27; 249(3323): 10–11.Published online 2021 Mar 3. doi: 10.1016/S0262-4079(21)00303-1PMCID: PMC7927578PMID: 33686318 Abstract Almost half of children who contract covid-19 may have lasting symptoms, which should factor into decisions on reopening schools, A SERIOUS picture is emerging about the long-term health effects of covid-19 in some children, with UK politicians calling the lack of acknowledgment of […]

COVID-19 and the liver

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 and the liver

Authors: Dinesh Jothimani, Radhika Venugopal,∗Mohammed Forhad Abedin, Ilankumaran Kaliamoorthy, and Mohamed Rela J Hepatol. 2020 Nov; 73(5): 1231–1240.Published online 2020 Jun 15. doi: 10.1016/j. jhep.2020.06.006PMCID: PMC7295524PMID: 32553666 Abstract The current coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has become a major public health crisis over the past few months. Overall case fatality rates range between 2–6%; […]

Colchicine: A Possible COVID-19 Long haul Cardiac Therapy

Posted on | Posted on John Murphy | Leave a Comment on Colchicine: A Possible COVID-19 Long haul Cardiac Therapy

Last Updated: December 16, 2021 Last Updated: December 16, 2021 Colchicine is an anti-inflammatory drug that is used to treat a variety of conditions, including gout, recurrent pericarditis, and familial Mediterranean fever.1 Recently, the drug has been shown to potentially reduce the risk of cardiovascular events in those with coronary artery disease.2 Colchicine has several potential mechanisms of action, […]

The Role of Colchicine in Pericardial Syndromes

Posted on | Posted on John Murphy | Leave a Comment on The Role of Colchicine in Pericardial Syndromes

Authors: George Lazaros 1, Massimo Imazio 2, Antonio Brucato 3, Charalambos Vlachopoulos 1, Emilia Lazarou 1, Dimitrios Vassilopoulos 4, Dimitris Tousoulis 1PMID: 29336245 DOI: 10.2174/1381612824666180116101823 Curr Pharm Des . 2018;24(6):702-709. doi: 10.2174/1381612824666180116101823. Abstract Background: Colchicine is an old drug originally employed for the treatment of inflammatory disorders such as acute gout and familiar Mediterranean fever. Methods: In the past few decades, colchicine has been at the forefront of the pharmacotherapy of several […]

Acute pericarditis as a primary presentation of COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Acute pericarditis as a primary presentation of COVID-19

Authors:Rajesh Kumar1, Jathinder Kumar1, Caroline Daly and Sadat Ali Edroos http://orcid.org/0000-0002-3267-63502 Abstract The COVID-19 pandemic is a highly contagious viral illness which conventionally manifests primarily with respiratory symptoms. We report a case whose first manifestation of COVID-19 was pericarditis, in the absence of respiratory symptoms, without any serious complications. Cardiac involvement in various forms is possible in COVID-19. We […]